Cardio-oncology & other

Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis

Eur Heart J Cardiovasc PharmacotherPublished Systematic review and meta-analysis

Pooled result · Breast cancer recurrenceResult — go to the resultHazard ratio 0.76 95% CI 0.67–0.87

Authors' conclusion

Among patients with breast cancer, statin use post-diagnosis decreases the risk of breast cancer recurrence and breast cancer mortality. Furthermore, lipophilic statins exhibit an additional advantage of reduction in all-cause mortality.

Study context

Population
Patients with breast cancer
Participants
156,448 patients15 studies
Comparison
Post-diagnostic statin use vs no statin use
Outcome
Breast cancer recurrence
Methodological detailsrandom-effect model, Search of PubMed, Embase and Scopus from inception to 30 May 2023
  • Random-effect model
  • Search of PubMed, Embase and Scopus from inception to 30 May 2023

Pooled result

As reported in the abstract

Hazard ratio

0.76

95% CI 0.67–0.87

Statin usersvs Non-statin users
HR 0.76 (95% CI 0.67–0.87)

Further pooled results

OutcomeHR (95% CI)
Breast cancer recurrence, by statin type (subgroup)Statin usersvs Non-statin usersLipophilic statins0.73 (0.63–0.85)
Breast cancer recurrence, by statin type (subgroup)Statin usersvs Non-statin usersHydrophilic statins1.17 (0.82–1.68)
Breast cancer mortalityStatin usersvs Non-statin usersAll statins0.80 (0.66–0.96)
Breast cancer mortalityStatin usersvs Non-statin usersLipophilic statins0.85 (0.74–0.99)
All-cause mortalityStatin usersvs Non-statin usersAll statins0.82 (0.66–1.02)
All-cause mortalityStatin usersvs Non-statin usersLipophilic statins0.84 (0.75–0.93)

Original publication

Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. Published 10 August 2023. doi:10.1093/ehjcvp/pvad057

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.